Lv4
610 积分 2021-08-30 加入
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors
18天前
已完结
Prevalence of HER2 overexpression and amplification in squamous cell carcinoma of the esophagus: A systematic review and meta-analysis
1个月前
已完结
HER2-targeted therapies — a role beyond breast cancer
1个月前
已完结
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
2个月前
已完结
Different inhibitory capacities of human and mouse KLRG1 are linked to distinct disulfide‐mediated oligomerizations
2个月前
已完结
Leading AI-Driven Drug Discovery Platforms: 2025 Landscape and Global Outlook
3个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
3个月前
已完结
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
3个月前
已完结
Validation of a clinically relevant humanized mouse model for the safety assessment of 4-1BB agonists utomilumab and urelumab
3个月前
已关闭
A BACH1 inhibitor ameliorates myocardial infarction and limb ischemia in mice
4个月前
已完结
Adis Drug Report: Anti-ADAM9 Antibody-drug conjugate DB 1317 (Duality Biologics)
皖公网安备34019202002308
